Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Calithera Biosciences
Calithera Biosciences
The 2023 Biotech Graveyard
Fierce Biotech
Tue, 10/31/23 - 11:34 am
biotech
Rubius Therapeutics
Nabriva Therapeutics
Calithera Biosciences
Goldfinch Bio
Antios Therapeutics
Magenta Therapeutics
Coda Biotherapeutics
Aristea Therapeutics
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace
Thu, 02/16/23 - 11:18 am
layoffs
Grifols
Frequency Therapeutics
Eliem Therapeutics
Aligos Therapeutics
Thermo Fisher Scientific
Magenta Therapeutics
Eisai
Amgen
Y-mAbs Therapeutics
Century Therapeutics
Elevation Oncology
Calithera Biosciences
Editas Medicine
Verily
Abzena
Calithera buys itself a plan B
EP Vantage
Tue, 10/19/21 - 10:43 am
Calithera Biosciences
Takeda
telaglenastat
sapanisertib
mivovatinib
lung cancer
B cell lymphoma
Calithera flunks phase 2 cancer trial, axes 35% of staff
Fierce Biotech
Mon, 01/4/21 - 10:25 am
Calithera Biosciences
clinical trials
telaglenastat
renal cell carcinoma
layoffs
The Week Ahead In Biotech: Spotlight On ESMO Conference
Yahoo/Benzinga
Sun, 09/22/19 - 11:10 pm
JNJ
daratumumab
Urogen
Rhythm Pharmaceuticals
Anavex
Aravive Biologics
TrovaGene
Incyte
AstraZeneca
Roche
Amgen
Aslan
G1 Therapeutics
GSK
Calithera Biosciences
Seattle Genetics
Immunomedics
Checkpoint Therapeutics
Aileron Therapeutics
Genocea Biosciences
AbbVie
Zymeworks
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Yahoo/Benzinga
Sun, 02/10/19 - 11:08 pm
Motif Biosciences
Iclaprim
Merck
Keytruda
melanoma
JNJ
esketamine
ASCO
Pfizer
Veru. earnings
Aveo Pharmaceuticals
Calithera Biosciences
FDA Fast Tracks Calithera Biosciences' CB-839 in Combination with Cabozantinib for Advanced Renal Cell Carcinoma
CP Wire
Wed, 04/18/18 - 07:24 pm
Calithera Biosciences
CB-839
cabozantinib
metastatic renal cell carcinoma
3 Strong Biotech Stocks In 2017
Forbes
Mon, 09/4/17 - 10:36 pm
Regeneron
Calithera Biosciences
Dynavax Technologies